Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 1 patent

Readers on

mendeley: 6 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

IL-2RBETA-SELECTIVE AGONISTS IN COMBINATION WITH AN ANTI-CTLA-4 ANTIBODY OR AN AN ANTI-PD-1…

Grant EP-3134123-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.